[31 July 2013]
Products Affected - Description
All products are currently available.
Reason for the Shortage
- B.Braun states theophylline in dextrose injection was on shortage due to increased demand.
- B.Braun is the sole manufacturer of theophylline in dextrose injection.
- Baxter and Hospira discontinued their theophylline in dextrose injection presentations in 2010.
Theophylline in 5% Dextrose Injection, B.Braun
80 mg/100 mL, 500 mL premixed bag (NDC 00264-9554-10)
Estimated Resupply Dates
B.Braun has theophylline in 5% dextrose injection available.
July 31, 2013; May 30, 2013; May 1, 2013; April 15, 2013, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins